| Pharmaceutical active ingredients: |
| Imatinib Mesylate |
| Available forms, composition and doses of Gleevec: |
| Capsules; Oral; Imatinib Mesylate 100 mgCapsules; Oral; Imatinib Mesylate 50 mgTablets; Oral; Imatinib Mesylate 100 mgTablets; Oral; Imatinib Mesylate 400 mg |
| Gleevec medical category: |
| Human:Antineoplastic agentsTargeted cancer therapy |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| L01XE01 - Imatinib |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Novartis |
| Related documents and information about Gleevec: |
| Gleevec prescribing information (PDF) |